Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
30m agoSunrun Prices $584 million Securitization of Residential Solar and Storage Assets
31m agoMadison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
55m agoUltra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
55m agoGridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
55m agoRush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend
Pharvaris Bv logo

Pharvaris Bv

About

Pharvaris Bv (NASDAQ:PHVS) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 20 2026
Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference
Apr 2 2026
Pharvaris Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar 11 2026
Validation of Patient-Reported Outcomes in the On-Demand Treatment of Hereditary Angioedema Attacks Published in Clinical Reviews in Allergy & Immunology
Mar 2 2026
Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026
Feb 10 2026
Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting

Financials

Revenue
$0
Market Cap
$1.86 B
EPS
-3.44

Community Chat

Ask AI

6ix6ixAIEvents